Related Experiment Video
Updated: Jan 18, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Anti-N-methyl-D-aspartate Receptor Encephalitis
Gregory Tanquary1, William Fraser1, Kaitlin M Bowers2
1Emergency Medicine, OhioHealth Doctors Hospital, Columbus, USA.
Anti-N-methyl-D-aspartate receptor (NMDA) encephalitis is an underrecognized neurological disorder. Early suspicion is crucial for prompt diagnosis and treatment of this condition, often presenting in young women.
Area of Science:
- Neurology
- Immunology
- Neuroscience
Background:
- Anti-N-methyl-D-aspartate receptor (NMDA) encephalitis is an autoimmune disorder.
- It is often misdiagnosed as psychiatric illness or delirium.
- The condition predominantly affects young females and is associated with ovarian teratomas.
Observation:
- A case of anti-NMDA encephalitis in a young female is presented.
- The patient exhibited progressive mental status changes and neurological abnormalities.
- Symptoms evolved during her emergency department stay.
Findings:
- The case highlights the diagnostic challenges of anti-NMDA encephalitis.
- It underscores the importance of recognizing neurological signs amidst psychiatric symptoms.
- Ovarian teratoma is a common co-occurrence.
Implications:
- Increased awareness and a high index of suspicion are vital for early diagnosis.
- Timely investigation and appropriate treatment can improve patient outcomes.
- This condition requires a multidisciplinary approach involving neurology, immunology, and gynecology.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists